In this study, we investigate for the first time the ability of GEN to enhance TLR3-mediated signaling in MCF-7 and MDA-MB-231 breast cancer cells, both alone and in combination with Poly I:C, a synthetic TLR3 agonist. This evidence concerns the gene TLR3 and breast carcinoma.